sulfamethoxazole has been researched along with Diabetes Mellitus, Type 2 in 2 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Excerpt | Relevance | Reference |
---|---|---|
"We describe 58 adult patients with melioidosis in Cambodia (2007-2010)." | 1.37 | Melioidosis, phnom penh, Cambodia. ( De Smet, B; Jacobs, J; Kham, C; Koole, O; Kruy, L; Lynen, L; Phe, T; Thai, S; Veng, CH; Vlieghe, E, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Khan, U | 1 |
Seetharaman, S | 1 |
Merchant, R | 1 |
Vlieghe, E | 1 |
Kruy, L | 1 |
De Smet, B | 1 |
Kham, C | 1 |
Veng, CH | 1 |
Phe, T | 1 |
Koole, O | 1 |
Thai, S | 1 |
Lynen, L | 1 |
Jacobs, J | 1 |
2 other studies available for sulfamethoxazole and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Neuroglycopenic Seizures: Sulfonylureas, Sulfamethoxazole, or Both?
Topics: Aged, 80 and over; Diabetes Mellitus, Type 2; Drug Interactions; Emergency Service, Hospital; Female | 2017 |
Melioidosis, phnom penh, Cambodia.
Topics: Adolescent; Adult; Aged; Burkholderia pseudomallei; Cambodia; Carbapenems; Cephalosporins; Diabetes | 2011 |